Last updated on May 2016

A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women M12-817


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Uterine Fibroids | Menstrual Disorders
  • Age: 21 Years
  • Gender: Female

Eligibility Criteria:

Please contact us. Must be 21 years old or older.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.